ADA-SCID

GSK picks up NICE recommendation for Strimvelis, a €594,000 gene therapy
Fierce Pharma
Mon, 10/23/17 - 09:55 pm
GSK
NICE
UK
Strimvelis
gene therapy
ADA-SCID
GSK enters pay-for-performance deal for gene therapy
BioPharma Dive
Wed, 08/17/16 - 06:39 pm
GSK
pay-for-performance
gene therapy
ADA-SCID
Strimvelis
Glaxo Turns its Eye to ‘Bubble Boy Disease’ in Rare Disease Push
WSJ Online
Mon, 10/18/10 - 01:37 pm
GSK
ADA-SCID